Generic name:coagulation factor viia recombinant human
Dosage form: intravenous infusion
Medically reviewed by Drugs.com. Last updated on Mar 22, 2022.
On This Page
- Boxed Warning
- Indications and Usage
- Dosage and Administration
- Dosage Forms and Strengths
- Contraindications
- Warnings and Precautions
- Adverse Reactions/Side Effects
- Clinical Studies
- Drug Interactions
- Use In Specific Populations
- Overdosage
- Description
- Clinical Pharmacology
- Nonclinical Toxicology
- How Supplied/Storage and Handling
- Patient Counseling Information
WARNING: THROMBOSIS
●Serious arterial and venous thrombotic events may occur following administration of SevenFACT®.[See Warnings and Precautions (5.1)]
●Discuss the risks and explain the signs and symptoms of thrombotic and thromboembolic events to patients who will receive SevenFACT®.
●Monitor patients for signs or symptoms of activation of the coagulation system and for thro...
